Trademarkia Logo

Canada

C$
EMPOWER PHARM & DESIGN
REGISTERED

on 6 Jul 2022

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

EMPOWERPHARM INC.

5575 North Service RoadSuite 603Burlington

ONTARIO

CA

L7L6M1

Serial Number

1922375 filed on 27th Sept 2018

Registration Number

TMA1133516 registered on 6th Jul 2022

Registration expiry Date

6th Jul 2032

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

EMPOWER PHARM & DESIGN

Trademark usage description

natural health products, namely, glucosamine, turmeric supplements, dietary supplements to aid digestion, melatonin, sleep support supplements, fish o Read More

Vienna Information


27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 22

Monograms formed of intertwined, overlapping or otherwise combined lettersMonogrammes formés par des lettres enlacées, se chevauchant ou combinées autrement

2 . 9 . 1

Hearts -- Note: Including also hearts represented as a symbol or on playing cards.Coeurs -- Note: Y compris les coeurs représentés comme symboles ou figurant sur des jeux de cartes.

Classification Information


Class [005]
Natural health products, namely, glucosamine, turmeric supplements, dietary supplements to aid digestion, melatonin, sleep support supplements, fish oils, probiotics in tablet, capsule, gummy vitamin and liquid form; vitamin supplements; mineral supplements; vitamin and mineral food supplements; vitamin and mineral dietary supplements; vitamin preparations; mineral preparations; multivitamins; prenatal vitamins; calcium supplements; nutritional supplements for general health and well-being, namely magnesium in tablets, capsules, gummies, and liquids; dietary supplements for promoting weight loss; over the counter medications for treating aches, pains, headaches, arthritis pain, sprains, and for treatment of minor joint injuries and muscle soreness, nonsteroidal anti-inflammatory drugs (NSAIDs), ibuprofen, naproxen sodium, acetaminophen, cold, sore throat and cough medications, guaifenesin, liquid cough medicines with dextromethorphan, decongestant nasal sprays, pseudoephedrine, phenylephrine, allergy medications, antihistamine pills and liquids, diphenhydramine, chlorpheniramine, brompheniramine, loratadine, fexofenadine, cetirizine, stomach upset medications, namely probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system, antidiarrhea medicines, loperamide, bismuth, nausea treatment preparations, pharmaceutical preparations for the treatment of vomiting and motion sickness, dimenhydrinate; cannabidiol (CBD) oil for medical purposes; cannabidiol (CBD) for medical purposes; cannabidiol (CBD) for medical purposes in the form of suppositories, sublingual doses that dissolve in the mouth, creams, ointments, and doses for absorption in the mucous membranes; tablets, capsules, gummies, suppositories, skin patches, sublingual doses, extended release tablets and liquids for therapeutic purposes containing cannabidiol (CBD); herbal supplements containing cannabidiol (CBD); Liquid nutritional supplement containing cannabidiol (CBD) for treating, reducing or improving symptoms of various conditions, namely, pain, anxiety, depression, cancer, acne, skin conditions, neuroprotection, cardiovascular health, arthritis, inflammation, autoimmune conditions, epileptic seizures, nausea, appetite, inflammatory bowel disease, and insomnia; tetrahydrocannabinol (THC) for medical purposes; tetrahydrocannabinol (THC) for medical purposes in sublingual doses and doses for absorption in the mucous membranes; tablets, capsules, gummies, suppositories, skin patches, sublingual doses, extended release tablets and liquid for therapeutic purposes containing tetrahydrocannabinol (THC) and containing a combination of tetrahydrocannabinol (THC) together with cannabidiol (CBD).


Classification kind code

11

Mark Details


Serial Number

1922375

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 15th Jun 2022
Registration Pending
Submitted for opposition 191
on 15th Jun 2022
Registration Fee Notice Sent
Submitted for opposition 42
on 23rd Mar 2022
Advertised
Submitted for opposition 26
on 20th Jan 2022
Approved
Submitted for opposition 27
on 20th Jan 2022
Approval Notice Sent
Submitted for opposition 22
on 6th Oct 2020
Search Recorded
Submitted for opposition 20
on 6th Oct 2020
Examiner's First Report
Submitted for opposition 31
on 3rd Oct 2018
Formalized
Submitted for opposition 1
on 28th Sept 2018
Created
Submitted for opposition 30
on 27th Sept 2018
Filed